MPLN buys MiSeqDx, 4/14
April 2014—Molecular Pathology Laboratory Network, of Maryville, Tenn., acquired the Illumina MiSeqDx, a next-generation sequencing system cleared by the FDA for targeted sequencing of human genomic DNA.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Partners: UCSF, Quest, 4/14
April 2014—UC San Francisco and Quest Diagnostics formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine for improved patient care, treatment, and outcomes.
DNA, RNA stabilization reagents
April 2014—In a licensing agreement between Biomatrica and ATCC, Biomatrica will supply DNAstable and RNAstable reagents for the stabilization of DNA and RNA standards.
Siemens, Pfizer to collaborate, 4/14
April 2014—Siemens Healthcare Diagnostics entered into a master collaboration agreement with Pfizer to design, develop, and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline.
Licensing agreement for GastroPanel, 4/14
April 2014—Finnish health care company Biohit Oyj and Randox Laboratories signed a licensing agreement giving Randox the worldwide licensing rights for GastroPanel.
Audit Web site, 4/14
April 2014—Audit MicroControls launched a new Web site, adding online ordering, access to Auditor QC, peer review data retrieval, and search functions by instrument, analyte, or indication. It also offers information about quality control products, calibration verification/linearity products, Audit Ship, and Audit Faxback.
Artus C. difficile kit, 4/14
April 2014—IMDx’s artus C. difficile QS-RGQ kit received CE marking for use with QIAsymphony SP/AS and Rotor-Gene Q instruments. Concurrently, in December 2013, a Premarket Notification 510(k) for the test was submitted to the FDA for review.
Troponin I POC test
April 2014—Trinity Biotech’s Meritas Troponin I (TnI) point-of-care test obtained CE marking. The test enables accurate triage and intervention for emergency department patients with possible myocardial infarction; results are available in 15 minutes.
RBCX cleared on Spectra Optia system, 4/14
April 2014—Terumo BCT received FDA 510(k) clearance for red blood cell exchange on the Spectra Optia Apheresis System.
Control LQ Glycohemoglobin A1c, 4/14
April 2014—Audit MicroControls added to its line of products the Control LQ Glycohemoglobin A1c—a liquid bi-level reference control consisting of human blood–based solutions.